Opening Plenary Panel: Thriving or Surviving – An Analysis of the Advanced Therapies Landscape Within Europe & What the Future Holds
06 Sep 2023
09:00
Auditorium
Panel Participants:
Chairperson: Anthony Davies, Founder & Chief Executive Officer, Dark Horse Consulting Group
- Ben Doak, Head of Innovative Treatments, NHS England
- Elisabetta Zanon, Director of EU Public Affairs & Advocacy, Alliance for Regenerative Medicine
- Helen Tayton-Martin, Chief Business & Strategy Officer, Adaptimmune
- Almira Bartolome, Executive Director, Commercial Development, Advanced Therapies & Vaccines, FUJIFILM Diosynth Biotechnologies
- Miguel Forte, Chief Executive Officer, Kiji Therapeutics, President-Elect, ISCT